$5.6 Verdict in Risperdal Case

Janssen Pharmaceuticals, a Johnson & Johnson unit was hit with a $5.6 million dollar verdict.  During a clinical study, a young man’s heart abnormalities were allegedly ignored by Janssen, resulting in his death.  

More information at the 360Law website.